Modification of non-conservative double-strand break (DSB) rejoining activity after the induction of cisplatin resistance in human tumour cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6690135.pdf
Reference34 articles.
1. Bill, C. A., Yu, Y., Miselis, N. R., Little, J. B. & Nickoloff, J. A. (1997). A role for p53 in DNA end rejoining by human cell extracts. Mutant Res 385: 21–29.
2. Britten, R. A., Warenius, H. M., Masters, J. R. W. & Peacock, J. H. (1993). The differential induction of collateral resistance to 62.5 MeV (p→Be+) neutrons and 4 MeV photons by exposure to cis-platinum. Int J Radiat Oncol Biol Phys 26: 837–843.
3. Britten, R. A., Warenius, H. M., Carraway, A. V. & Murray, D. (1994). Differential modulation of radiosensitivity following induction of cis-platinum resistance in radiation-sensitive and radiation-resistant human tumor cells. Radiat Oncol Invest 2: 25–31.
4. Britten, R. A., Liu, D., Kuny, S. & Allalunis-Turner, M. J. (1997). Differential level of DSB repair fidelity effected by nuclear protein extracts derived from radiosensitive and radioresistant human tumour cells. Br J Cancer 76: 1440–1447.
5. Bryant, P. E. & Liu, N. (1994). Responses of radiosensitive repair-proficient cell lines to restriction endonucleases. Int J Radiat Biol 66: 597–601.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells;Drug Design, Development and Therapy;2019-11
Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells
2. Nanopreparations to overcome multidrug resistance in cancer;Advanced Drug Delivery Reviews;2013-11
3. Inhibition of ERβ Induces Resistance to Cisplatin by Enhancing Rad51–Mediated DNA Repair in Human Medulloblastoma Cell Lines;PLoS ONE;2012-03-16
4. An overview of cancer multidrug resistance: a still unsolved problem;Cellular and Molecular Life Sciences;2008-06-26
5. Mechanisms of resistance to cisplatin and carboplatin;Critical Reviews in Oncology/Hematology;2007-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3